NEW YORK (360Dx) – A*STAR and its spinoff One BioMed said today that they recently launched a Singapore $9 million (US$6.6 million) lab with an aim to commercialize a point-of-care diagnostic kit within the next five years that can concurrently test for up to 20 types of infectious diseases in 20 minutes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.